Cite
MLA Citation
S.S. Neelapu et al.. “AXICABTAGENE CILOLEUCEL (AXI‐CEL; KTE‐C19) IN PATIENTS WITH REFRACTORY AGGRESSIVE NON‐HODGKIN LYMPHOMAS (NHL): PRIMARY RESULTS OF THE PIVOTAL TRIAL ZUMA‐1.” Hematological oncology, vol. 35, n.d., p. 28. http://access.bl.uk/ark:/81055/vdc_100047524133.0x000028